Objective: Mortality rates in the year following new antipsychotic medication starts for
neuropsychiatric symptoms of dementia were compared with rates after starts of other …

Objective: The use of antipsychotics to treat the behavioral symptoms of dementia is
associated with greater mortality. The authors examined the mortality risk of individual …

Background: Antipsychotic drugs are widely used to manage behavioral and psychological
symptoms in dementia despite concerns about their safety. Objective: To examine the …

Background/Aims: To evaluate whether dementia patients prescribed antipsychotic drugs
have a higher mortality compared to unexposed patients, and to investigate whether there …

OBJECTIVES: To estimate mortality risk associated with individual commonly prescribed
antipsychotics. DESIGN: Five‐year retrospective study. SETTING: Veterans national …

Context Use of atypical antipsychotics for neuropsychiatric symptoms of dementia increased
markedly in the 1990s. Concerns about their use began to emerge in 2002, and in 2005, the …

Objective To investigate short-and long-term mortality risk associated with the use of
antipsychotics in dementia outpatients, assessing the risk over specific time frames and …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However …

Background We investigated the mortality risk associated with the initiation of antipsychotic
treatment among patients with dementia and whether comorbidities related to the …

Objective: A recent meta-analysis has indicated that, in patients with dementia, the use of
atypical antipsychotics is associated with an excess mortality. Later observational studies …